These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6978557)

  • 21. Hemolytic transfusion reaction due to interdonor kell incompatibility. Report of two cases and review of the literature.
    Reiner AP; Sayers MH
    Arch Pathol Lab Med; 1990 Aug; 114(8):862-4. PubMed ID: 2198004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.
    Pinkerton PH; Coovadia AS; Goldstein J
    Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of a severe transfusional problem in a patient with alloantibody to Kpb (K4).
    Kohan AI; Reybaud JF; Salamone HJ; Rey JA; Rey CE; Villaravid N; Papa S; Cyrulik Goldztein S; Calahonra R; Sanchez Avalos JC
    Vox Sang; 1990; 59(4):216-7. PubMed ID: 1705734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant.
    López A; de la Rubia J; Arriaga F; Jiménez C; Sanz GF; Carpio N; Marty ML
    Transfusion; 1998 Mar; 38(3):247-51. PubMed ID: 9563404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Problem-solving in immunohematology: direct compatibility laboratory test ].
    Mannessier L; Roubinet F; Chiaroni J
    Transfus Clin Biol; 2001 Dec; 8(6):481-4. PubMed ID: 11802611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Kpa-induced severe delayed hemolytic transfusion reaction.
    Koshy R; Patel B; Harrison JS
    Immunohematology; 2009; 25(2):44-7. PubMed ID: 19927619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved antiglobulin tests to detect difficult antibodies: detection of anti-Kell by LISS.
    Voak D; Downie M; Haigh T; Cook N
    Med Lab Sci; 1982 Oct; 39(4):363-70. PubMed ID: 7176849
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful transfusion results using Rg(a+) blood in four patients with anti-Rga.
    Strohm PL; Molthan L
    Vox Sang; 1983; 45(1):48-52. PubMed ID: 6880144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of Kn(a+) McC(a+) red cells in a patient with anti- "Kna/McCa".
    Ballas SK; Viggiano E; Draper EK
    Transfusion; 1984; 24(1):22-4. PubMed ID: 6695436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed hemolytic transfusion reactions. Evidence of the need for an improved pretransfusion compatibility test.
    Moore SB; Taswell HF; Pineda AA; Sonnenberg CL
    Am J Clin Pathol; 1980 Jul; 74(1):94-7. PubMed ID: 7395821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoanti-K antibody mimicking an alloantibody.
    Viggiano E; Clary NL; Ballas SK
    Transfusion; 1982; 22(4):329-32. PubMed ID: 7101426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolytic disease of the newborn due to anti-Jsb.
    Purohit DM; Taylor HL; Spivey MA
    Am J Obstet Gynecol; 1978 Aug; 131(7):755-6. PubMed ID: 686069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune hemolytic anemia and the Kell blood groups.
    Marsh WL; Oyen R; Alicea E; Linter M; Horton S
    Am J Hematol; 1979; 7(2):155-62. PubMed ID: 539592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemolytic transfusion reaction due to anti-Kell undetectable in low-ionic-strength solutions.
    Molthan L; Strohm PL
    Am J Clin Pathol; 1981 Apr; 75(4):629-31. PubMed ID: 7223723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood transfusion complications due to Kell factor incompatibility of the transfused blood].
    Skachilova NN; Umnova MA; Morozova AD; Shakhsuvarov VD; Beliaev VV
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):16-20. PubMed ID: 7156084
    [No Abstract]   [Full Text] [Related]  

  • 38. [Case of Rh E and Kell antigen sensitization by blood transfusion].
    Trifunović S; Pavlović P; Tomasević R; Krstić C
    Bilt Hematol Transfuz; 1975; 3(1-2):83-8. PubMed ID: 817715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed hemolytic transfusion reaction: case report.
    Monaghan P
    Mil Med; 1978 Feb; 143(2):122. PubMed ID: 416381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.